Patterns of Hepatitis B, Hepatitis C and HIV Among Blood Donors in Samtah-Jazan Region.
HBV
HCV
HIV
Transfusion-transmitted infections
Journal
Journal of epidemiology and global health
ISSN: 2210-6014
Titre abrégé: J Epidemiol Glob Health
Pays: Switzerland
ID NLM: 101592084
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
28
02
2022
accepted:
18
07
2022
pubmed:
31
7
2022
medline:
16
9
2022
entrez:
30
7
2022
Statut:
ppublish
Résumé
Transfusion-transmitted infectious agents are amongst the major health burden worldwide. The purpose of this study was to evaluate the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) among blood donors in Samtah General Hospital, Jazan region, Saudi Arabia. In this retrospective study, blood donation records of all blood donors recruited between January 2019 and August 2020 were included for data acquisition. A total of 4977 blood donors' records were reviewed and data were analysed. Hepatitis B profile showed 0.60% blood donors positive for hepatis B surface antigen (HBsAg). Nucleic acid testing (NAT) showed the presence of HBV-DNA in 0.4% of the blood donors. Anti-HBs and anti-HBc antibodies were reactive in 3.34% and 7.31% blood donors' units, respectively. Anti-HCV antibodies were reactive among 54 (1.09%) blood donors. Upon reviewing the NAT analysis results, 0.16% (08) blood donors showed the presence of HCV-RNA in their blood units. Anti-HIV antibodies were reactive in 8 (0.16%) blood donors. It is concluded that the frequency of HBsAg is comparatively lower while anti-HCV positivity is higher in Samtah, Jazan as a region compared to other regions of the country. Further studies are warranted to evaluate the cause of HCV infection in this area. Frequency of HIV is uncommon in this area.
Sections du résumé
BACKGROUND AND OBJECTIVE
Transfusion-transmitted infectious agents are amongst the major health burden worldwide. The purpose of this study was to evaluate the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) among blood donors in Samtah General Hospital, Jazan region, Saudi Arabia.
MATERIAL AND METHODS
In this retrospective study, blood donation records of all blood donors recruited between January 2019 and August 2020 were included for data acquisition. A total of 4977 blood donors' records were reviewed and data were analysed.
RESULTS
Hepatitis B profile showed 0.60% blood donors positive for hepatis B surface antigen (HBsAg). Nucleic acid testing (NAT) showed the presence of HBV-DNA in 0.4% of the blood donors. Anti-HBs and anti-HBc antibodies were reactive in 3.34% and 7.31% blood donors' units, respectively. Anti-HCV antibodies were reactive among 54 (1.09%) blood donors. Upon reviewing the NAT analysis results, 0.16% (08) blood donors showed the presence of HCV-RNA in their blood units. Anti-HIV antibodies were reactive in 8 (0.16%) blood donors.
CONCLUSION
It is concluded that the frequency of HBsAg is comparatively lower while anti-HCV positivity is higher in Samtah, Jazan as a region compared to other regions of the country. Further studies are warranted to evaluate the cause of HCV infection in this area. Frequency of HIV is uncommon in this area.
Identifiants
pubmed: 35907148
doi: 10.1007/s44197-022-00051-7
pii: 10.1007/s44197-022-00051-7
pmc: PMC9470796
doi:
Substances chimiques
Hepatitis B Antibodies
0
Hepatitis B Surface Antigens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
304-310Informations de copyright
© 2022. The Author(s).
Références
WHO. Progress report on HIV, viral hepatitis and sexually transmitted infections, vol 53; 2019.
Zaaijer HL. Prevention of transfusion-transmitted infections: dilemmas. Front Med. 2017;4:1–3. https://doi.org/10.3389/fmed.2017.00221 .
doi: 10.3389/fmed.2017.00221
Roman L, Armstrong B, Smart E. Donation testing and transfusion transmissible infections. ISBT Sci Ser. 2020;15:192–206. https://doi.org/10.1111/voxs.12597 .
doi: 10.1111/voxs.12597
Alaidarous M, Choudhary RK, Waly MI, Mir S, Bin Dukhyil A, Banawas SS, et al. The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia. J Infect Public Health. 2018;11:702–6. https://doi.org/10.1016/j.jiph.2018.04.008 .
doi: 10.1016/j.jiph.2018.04.008
pubmed: 29703711
Fong IW, Fong IW. Blood transfusion-associated infections in the twenty-first century: new challenges Current Trends and Concerns in Infectious Diseases. Berlin: Springer; 2020. p. 191–215. https://doi.org/10.1007/978-3-030-36966-8_8 .
doi: 10.1007/978-3-030-36966-8_8
Stramer SL, Dodd RY. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion. 2013;53:2375–83. https://doi.org/10.1111/trf.12371 .
doi: 10.1111/trf.12371
pubmed: 23926897
pmcid: 7169683
Shobokshi OA, Serebour FE, Al-Drees AZ, Mitwalli AH, Qahtani A, Skakni LI. Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J. 2003;20:25.
El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia; 2004.
Abdo AA, Sanai FM, Al-Faleh FZ. Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook. Saudi J Gastroenterol. 2012;18:349–57. https://doi.org/10.4103/1319-3767.103425 .
doi: 10.4103/1319-3767.103425
pubmed: 23150019
pmcid: 3530988
Alabdulmonem W, Shariq A, Alqossayir F, AbaAlkhail FM, Al-Musallam AY, Alzaaqi FO, et al. Sero-prevalence ABO and Rh blood groups and their associated transfusion-transmissible infections among blood donors in the Central Region of Saudi Arabia. J Infect Public Health. 2020. https://doi.org/10.1016/j.jiph.2019.12.004 .
doi: 10.1016/j.jiph.2019.12.004
pubmed: 31953019
Bamaga MS, Azahar EI, Al-Ghamdi AK, Alenzi FQ, Farahat FM. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks.[Erratum appears in Saudi Med J. 2009 Dec; 30(12):1616 Note: Al-Enzi, Faris Q [corrected to Alenzi, Faris Q]]. Saudi Med J. 2009;30:1416–21.
pubmed: 19882053
Fageeh WM. Should we screen for HIV in Saudi Arabia? JKAU Med Sci. 2010;17:45–54. https://doi.org/10.4197/Med .
doi: 10.4197/Med
Elbjeirami WM, Arsheed NM, Al-Jedani HM, Elnagdy N, Abou Eisha HM, Abdulwahab A, et al. Prevalence and trends of HBV, HCV, and HIV serological and NAT markers and profiles in saudi blood donors. J Blood Disord Transfus. 2015;6:3. https://doi.org/10.4172/2155-9864.1000280 .
doi: 10.4172/2155-9864.1000280
Bashawri LAM, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998–2001. Clin Lab Haematol. 2004;26:225–8. https://doi.org/10.1111/j.1365-2257.2004.00601.x .
doi: 10.1111/j.1365-2257.2004.00601.x
pubmed: 15163322
Morsi HA. Routine use of mini-pool nucleic acid testing (MP-NAT) multiplex assay for sero-negative blood donors. J Egypt Soc Haemat Res. 2011;7:1–5.
Alzahrani FM, Muzaheed SSS, Alomar AI, Acharya S, Elhadi N. Prevalence of Hepatitis B Virus (HBV) among blood donors in eastern Saudi Arabia: results from a five-year retrospective study of HBV seromarkers. Ann Lab Med. 2018;39:81–5. https://doi.org/10.3343/alm.2019.39.1.81 .
doi: 10.3343/alm.2019.39.1.81
pmcid: 6143475
Abdullah SM. Prevalence of hepatitis B and C in donated blood from the Jazan region of Saudi Arabia. Malays J Med Sci. 2013;20:42–7.
Committee on a National Strategy for the Elimination of Hepatitis B and C; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine; Buckley GJ, Strom BL E. Eliminating the Public Health Problem of Hepatitis B and C in the United States: phase one report. Washingt. Natl. Acad. Press, vol. June; 2016.
WHO. Executive summary—global hepatitis report, 2017. World Health Organ 2017.
WHO. Hepatitis B 2019. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b .
Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13:2436–41. https://doi.org/10.3748/wjg.v13.i17.2436 .
doi: 10.3748/wjg.v13.i17.2436
pubmed: 17552026
pmcid: 4146761
Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22:7824–40. https://doi.org/10.3748/wjg.v22.i34.7824 .
doi: 10.3748/wjg.v22.i34.7824
pubmed: 27678366
pmcid: 5016383
Roudot-Thoraval F. Epidemiology of hepatitis C virus infection. Clin Res Hepatol Gastroenterol. 2021;45:101596. https://doi.org/10.1016/j.clinre.2020.101596 .
doi: 10.1016/j.clinre.2020.101596
pubmed: 33610022
Aljumah AA, Babatin M, Hashim A, Abaalkhail F, Bassil N, Safwat M, et al. Hepatitis B care pathway in Saudi Arabia: current situation, gaps and actions. Saudi J Gastroenterol. 2019;25:73–80. https://doi.org/10.4103/sjg.SJG_421_18 .
doi: 10.4103/sjg.SJG_421_18
pubmed: 30720000
pmcid: 6457186
Al-Faleh FZ. Hepatitis B infection in Saudi Arabia. Ann Saudi Med. 1998;8:474–80.
doi: 10.5144/0256-4947.1988.474
Frank TD, Carter A, Jahagirdar D, Biehl MH, Douwes-Schultz D, Larson SL, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6:e831–59. https://doi.org/10.1016/S2352-3018(19)30196-1 .
doi: 10.1016/S2352-3018(19)30196-1
Al-Mozaini M, Alrahbeni T, Dirar Q, Alotibi J, Alrajhi A. HIV in the Kingdom of Saudi Arabia: can we change the way we deal with co-infections. Infect Drug Resist. 2021;14:111–7. https://doi.org/10.2147/IDR.S270355 .
doi: 10.2147/IDR.S270355
pubmed: 33500633
pmcid: 7822075
Sallam T, El-Bingawi H, Alzahrani K, Alzahrani B, Alzahrani A. Prevalence of hepatitis B and hepatitis C viral infections and impact of control program among blood donors in Al-Baha region, Saudi Arabia. Saudi J Health Sci. 2020;9:56–60. https://doi.org/10.4103/sjhs.sjhs_197_19 .
doi: 10.4103/sjhs.sjhs_197_19
Alshayea AI, Eid GE, El-Hazmi MM, Alhetheel AF. Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. Saudi Med J. 2016;37:1114–9. https://doi.org/10.15537/smj.2016.10.14705 .
doi: 10.15537/smj.2016.10.14705
pubmed: 27652363
pmcid: 5075376
AlMutairi HH, AlAhmari MM, Al-Zahran BH, Abbas IS, Al Ghamdi JAS, Raja AYA, et al. Prevalence of serological markers and nucleic acid for blood-borne viral infections in blood donors in Al-Baha, Saudi Arabia. J Infect Dev Ctries. 2016;10:619–25. https://doi.org/10.3855/jidc.6666 .
doi: 10.3855/jidc.6666
pubmed: 27367011
Alabdallat NG, Bin Dukhyil AAA. Significance of HBV NAT among HBS antigen-negative blood donors in Saudi Arabia. Lab Med. 2018;49:342–6. https://doi.org/10.1093/labmed/lmy023 .
doi: 10.1093/labmed/lmy023
pubmed: 29767761
El Beltagy KE, Al Balawi IA, Almuneef M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. Int J Infect Dis. 2008;12:495–9. https://doi.org/10.1016/j.ijid.2008.01.010 .
doi: 10.1016/j.ijid.2008.01.010
pubmed: 18400539
Alcantara JC, Alenezi FKM, Haj Ali OH. Seroprevalence and trends of markers of transfusion transmissible infections among blood donors: a 3-year hospital based-study. Int J Community Med Public Health. 2018;5:5031. https://doi.org/10.18203/2394-6040.ijcmph20184773 .
doi: 10.18203/2394-6040.ijcmph20184773
Sarah YAEGA, Sabry AEGAEHES, Maryam AAS. Seropositivity of TTIs among blood donors in Hail, Saudi Arabia, from 2014 to 2015. Asian Pac J Trop Dis. 2014;2016(6):141–6. https://doi.org/10.1016/S2222-1808(15)61000-3 .
doi: 10.1016/S2222-1808(15)61000-3
Madani TA. Sexually transmitted infections in Saudi Arabia. BMC Infect Dis. 2006;6:1–6. https://doi.org/10.1186/1471-2334-6-3 .
doi: 10.1186/1471-2334-6-3
Ibrahim EH, Bin Dajem AM, Heijan AA, Hadish HF, Zahar YA, Alshehri A, Kilany MMO. Hepatitis B vaccine reduced the prevalence of antibodies to hepatitis B core antigen in blood donors in Aseer Region, Saudi Arabia, Egypt. Acad J Biol Sci. 2014;6:13–22.
Al MF. Prevalence of transfusion-transmissible infections among blood donors in Riyadh: a tertiary care hospital-based experience. J Nat Sci Med. 2020;3:247–51. https://doi.org/10.4103/JNSM.JNSM .
doi: 10.4103/JNSM.JNSM